Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Patent update

29 Jun 2016 07:00

RNS Number : 5625C
WANdisco Plc
29 June 2016
 

 

 



29 June 2016

 

WANdisco plc

 

("WANdisco" or "the Company")

 

Patent update

 

 

Sheffield, UK - WANdisco (LSE: WAND), announces it has been granted a US Patent entitled "Distributed File System Using Consensus Nodes". In addition, a related patent application was approved, with assignment of the final patent number pending.

 

The patent and the approved application, covers the use of WANdisco's core replication technology, used across its entire range of Cloud, Big Data and ALM products, with the Hadoop Distributed File System (HDFS) and similarly architected Big Data file systems in the future.

 

Hadoop is a proven open source Big Data technology, having the ability to store virtually any type of data, including images, video and audio. It forms the backbone of many of the world's largest and most important databases utilized by companies such as Facebook, Yahoo, Netflix, Amazon and eBay. A number of the world's largest corporations across all industries are rapidly adopting Hadoop to replace costly and less flexible legacy enterprise data warehouse solutions, and they require the highest levels of resilience that only WANdisco's technology can bring. In addition, major cloud vendors such as Amazon, Google, Microsoft and IBM have Hadoop-as-a-service (HaaS) offerings that will also benefit from this technology.

 

With the approval of this most recent application, the Company has been granted a total of seven US patents. WANdisco currently has a further twenty-five patent applications pending both in the US and internationally.

 

David Richards, CEO of WANdisco, said:

 

"Continual innovation remains a key objective at WANdisco, protecting our competitive position and adding value to our business. Our growing patent portfolio reflects that ambition. On the specific patent, replication using our core technology integrated with the Hadoop Distributed File System (HDFS), or a future big data file system with a similar architecture to HDFS is covered. The Company believes that any future big data scale-out file systems will have many similar architectural elements to HDFS, meaning this grants provides broad future-proof protection."

 

END

 

Enquiries

 

WANdisco plc

via FTI Consulting LLP

David Richards, Chief Executive Officer

Phil Branston, VP Corporate Development & Investor Relations

FTI Consulting

+44 (0)203 727 1000

Matt Dixon / Dwight Burden / Rob Mindell

Investec (Joint Broker and NOMAD)

+44 (0)207 597 4000

Christopher Baird / Dominic Emery

UBS (Joint Broker)

Rahul Luthra / Sandip Dhillon

+44 (0)207 567 8000

 

About WANdisco plc

 

WANdisco (LSE: WAND) is a provider of enterprise-ready, non-stop software solutions that enable globally distributed organizations to meet today's data challenges of secure storage, scalability and continuous availability. WANdisco's products are differentiated by the company's patented, active data replication technology, serving crucial continuous availability requirements, including Hadoop Big Data and Application Lifecycle Management (ALM), including Apache Subversion and Git. Fortune Global 1000 companies, including Juniper Networks, Motorola, Intel and Halliburton, rely on WANdisco for performance, reliability, security and availability. For additional information, please visit www.wandisco.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAVVLFLQQFBBBQ
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.